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Summary. Acute and chronic stress, COVID-19 and 
male hypogonadism are interrelated.
The aim of the study – to analyze the literature on the 
interactions of stress, COVID-19 and male hypogonadism, 
to trace the main links in the pathogenesis.
Materials and Methods. The study examined 
scientific publications over the past decade, which are 
available on the Internet, the key words were "COVID-19", 
"male hypogonadism", "acute stress", "chronic stress", 
"pathogenesis".
Results. In order to study in more detail the effect of 
stress in COVID-19 on male hypogonadism, the pathogenetic 
chains of three separate vicious circles are considered 
separately: "COVID-19 and stress", "COVID-19 and male 
hypogonadism", "stress and male hypogonadism". Attention 
is paid to pathogenetic mechanisms in the presence of all 
three factors: COVID-19, stress and male hypogonadism.
Conclusions. The link between the effects of stress, 
COVID-19 and male hypogonadism has been proven. The 
main pathogenetic links of these interdependent processes 
are described.
Key words: men; stress; COVID-19; hypogonadism.
Етіологія та патогенез гіпогонадизму в чоловіків у 
сучасних умовах
Р. Б. Друзюк, О. В. Денефіль 
Тернопільський національний медичний університет 
імені І. Я. Горбачевського МОЗ України 
Резюме. Гострий та хронічний стреси, COVID-19 
та чоловічий гіпогонадизм взаємопов’язані між собою. 
Мета дослідження – проаналізувати літератур-
ні джерела щодо взаємовпливів стресу, COVID-19 та 
чоловічого гіпогонадизму, простежити основні ланки 
патогенезу.
Матеріали і методи. У дослідженні опрацьовано 
наукові публікації за останнє десятиліття, які до-
ступні у мережі «Інтернет», ключовими словами були 
«COVID-19», «чоловічий гіпогонадизм», «гострий стрес», 
«хронічний стрес», «гострий стрес», «патогенез».
Результати. З метою детальнішого вивчення впли-
ву стресу при COVID-19 на чоловічий гіпогонадизм, 
окремо розглянуто патогенетичні ланцюги трьох 
окремих хибних кіл: «COVID-19 та стрес», «COVID-19 
та чоловічий гіпогонадизм», «стрес та чоловічий гіпо-
гонадизм». Звернено увагу на патогенетичні механіз-
ми за наявності усіх трьох факторів: COVID-19, стрес 
та чоловічий гіпогонадизм.
Висновки. Доведено зваємозв’язок між впливами 
стресу, COVID-19 та чоловічого гіпогонадизму. Описа-
но основні патогенетичні ланки цих взаємозумовлених 
процесів.
Ключові слова: чоловіки; стрес; COVID-19; гіпогонадизм.
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INTRODUCTION
To date, in the course of repeated long-term ob-
servations and numerous scientific studies, there is a 
significant impact of stress on the pathophysiological 
mechanisms of many diseases. These include the in-
fluence of stressors on the development of male hy-
pogonadism and, conversely, the conditionality of the 
development of chronic stress by sexual dysfunction 
and deterioration of sexual intercourse due to hypo-
gonadism.
At the same time, as part of the latest research 
on the effects of coronavirus (COVID-19) on the hu-
man body, Chinese scientists have found that this vi-
rus has a detrimental effect on testicular function and 
male reproductive function. The researchers demon-
strated a relationship between coronavirus infection 
and the development of testicular failure [1,2], and 
substantiated the corresponding determinism of a 
worse prognosis for COVID-19 in men and low tes-
tosterone levels [3].
In a pandemic, stress becomes a factor that af-
fects people's lives in one way or another. For 
example, the situation of social isolation leads to 
long-term activation of the sympatho-adrenal system. 
In people who have lost a family member, recorded 
a particularly significant excretion of catecholamines 
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and acute damage to various organs and systems. 
People affected by COVID-19 were treated in medical 
institutions, separated from their relatives, saw deaths 
around them, and therefore had an increased excre-
tion of catecholamines (varying degrees of epineph-
rine and nor epinephrine). Of course, it complicates 
the course of diseases caused by the virus COVID-19.
Given the above, we can note the interconnected 
vicious circles that reinforce each other (Figure 1).
The aim of the study was to analyze the litera-
ture on the spread of male hypogonadism in acute 
and chronic stress and in epidemic of COVID-19, 
tracking the main links in the study of pathogenesis, 
drawing parallels with the interaction of these factors.
MATERIALS AND METHODS
The study examined scientific publications over the 
past decade, which are available on the Internet, the 
key words were "COVID-19", "male hypogonadism", 
"acute stress", "chronic stress", "pathogenesis".
RESULTS 
Stress and male hypogonadism. Stress is 
usually a natural phenomenon that affects behavior, 
physiological processes and neuroendocrine, neu-
rochemical, neural and immune responses. It is sup-
posed that many somatic and mental disorders are 
the result of chronic stress. Stress-induced gonadal 
dysfunction is observed not only in humans but also in 
all higher animals. Stress-induced gonadal dysfunc-
tion includes disorders of the hypothalamic-pituitary-
gonadal axis and spermatogenesis. Various stressors 
induce changes in the secretion of neurotransmitters 
and hormones, such as corticotropin-releasing hor-
mone, vasopressin, beta-endorphins, somatostatin, 
vasoactive intestinal polypeptide, prolactin, gonado-
tropin, thyroid-stimulating hormone, dopamine, sero-
tonin, neuropeptide Y, melatonin, adrenocorticotropic 
hormone (ACTH), glucocorticosteroids (GCS), ca-
techolamines and androgens [4].
In this context, it seems appropriate to consider 
separately the effects of acute and chronic stress 
(both related to the action of COVID-19 virus) on the 
hormonal status, because, despite the common links 
in the pathogenesis, the latter are marked by signifi-
cant differences in their hormonal changes.
Acute stress is accompanied by modification of 
testicular function mainly by cytokines and its fluc-
tuations due to gonadotropin concentrations, while 
chronic stress is accompanied by hypogonadotropic 
hypogonadism and impaired spermatogenesis of 
varying severity, up to spermatogenesis. The action 
of COVID-19 virus has a double detrimental effect 
on testicular function – stress cytokines and proin-
flammatory cytokines associated with the COVID-19 
virus.
Physiological stress, which does not yet disrupt 
the compensation mechanisms, to some extent in-
creases the production of somatotropic hormone. 
However, chronic stress causes increased soma-
tostatin production and suppression of somatotropin. 
Somatotropin deficiency causes mild fatigue, loss of 
sexual desire, loss of erection and oligo- or azoosper-
mia [5]. Somatostatin, on the other hand, causes sup-
pression of serotonin production and, consequently, 
frequent depressive and anxiety states that do not 
promote adequate sexual behavior.
Melatonin has a significant anti-stress effect. The 
role and functions of melatonin are unique and include: 
1) regulation of circadian and seasonal rhythms; 2) re-
gulation of the psycho-emotional and cognitive spheres; 
3) antioxidant, neuroprotective, geroprotective action; 
4) immunomodulatory action; 5) oncoprotective action; 
6) universal stress-protective effect. Melatonin realizes 
its effects in two ways: 1) through a system of specific 
melatonin receptors (MT1, MT2, MT3), which are dif-
ferent in function (excitatory and inhibitory), localization 
(membrane and nuclear) and are widely represented in 
the central nervous system and peripheral organs; 2) 
based on interaction with other nuclear receptors and 
subcellular structures due to free penetration through 
all tissue and histohematological barriers [6].
The effect of chronic stress, among other things, 
is marked by depletion of melatonin resources. This 
will manifest itself in insomnia at night and drowsiness 
during the day; disorders in the emotional sphere and 
cognitive activity; an even greater reduction in overall 
stress resistance. In addition, a decrease in the anti-
oxidant, neuroprotective, immunomodulatory proper-
ties of melatonin will increase the detrimental effects 
of the COVID-19 virus.
At the present stage, the importance of melatonin 
for maintaining spermatogenesis and regulating re-
productive function in men has been proven. Chronic 
melatonin deficiency, associated with sleep-wake dis-
orders, naturally leads to an increase in sex hormone 
deficiency and insulin resistance due to progres-
sive obesity and oxidative stress, including oxidative 
stress in sperm. That is, the lower the level of melato-
nin in the blood, the more pronounced is the oxidative 
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antioxidant and mitochondrial protector. According to 
many authors, melatonin plays the role of a kind of 
"testicular protector", protecting testicular tissue from 
ischemia, hypoxia, oxidative stress, including obesity, 
and, consequently, from irreversible loss of function-
ing germinogenic epithelium [7].
Dehydroepiandrosterone (or DHEA) is a hormone 
with androgenic activity. DHEA is responsible for the 
development of secondary sexual characteristics, main-
tenance of sexual function, and has an anabolic effect. 
90 % of the hormone is produced in the adrenal cor-
tex, the other 10 % is synthesized in men in the testicles 
and in the ovaries in women. Cholesterol is considered 
a precursor to DHEA, and other steroid hormones are 
consi dered successors. In men, DHEA is subject to 
conversion to stronger androgens – testosterone and 
andro stenedione, in women – estrogen and progeste-
rone. Hormone production continues under the control of 
ACTH. Chronic stress can lead to a decrease in DHEA, 
indicating the development of adrenal stress syndrome 
[8]. This, in turn, is accompanied by a decrease in the 
synthesis of testosterone and androstenediol.
Testosterone is the main sex steroid that provides 
reproductive function in the male body. On the other 
hand, as an anabolic hormone, it is involved in the re-
gulation of plastic and reparative processes [9, 23]. In 
the central nervous system, testosterone and its me-
tabolites work as neurosteroids, as they are involved 
in the formation of learning, memory, socio-behavioral 
motivation [10, 23]. Testosterone helps maintain an 
adequate body response to stress. In animal experi-
ments, testosterone has been shown to suppress 
the hypothalamic-pituitary-adrenocortical response to 
stress, while estrogen alleviates it [11, 23]. Stress in ani-
mals has been shown to inhibit testosterone synthesis 
and spermatogenesis due to blockade of gonadotropin 
receptors and, consequently, the absence of luteinizing 
hormone (LH) and follicle-stimulating hormone, leading 
to the cessation of testosterone and gametogenesis. 
On the other hand, suppression of testosterone secre-
tion in the case of chronic exposure to extreme exter-
nal factors is possible regardless of the high content of 
LH due to reduced sensitivity of the testes to the activa-
ting action of tropical hormones [13, 23]. The change in 
the function of the gonads in the presence of stress is 
largely due to the duration of exposure to the extreme 
factor, its nature, the initial state of the organism. These 
factors can directly affect both the central and periphe-
ral links not only of the hypothalamic-pituitary-gonadal 
system (HPGS), but also of other systems of response 
regulation, as they form a certain pathogenetic mecha-
nism of damage [14, 23]. The duration of stressors is 
a determining factor in testosterone synthesis. During 
animal experiments, due to the combination of stress 
with active exercise in the first time from the moment of 
exposure, an increase in the level of testosterone cir-
culating in the blood is observed, but later, in the case 
of long-term stressor, its decrease is observed [15, 
23]. The initial increase in testosterone release under 
stress is more related to the activation of HPGS, active 
gonadotropin secretion and, consequently, LH. Similar 
changes in testosterone concentration occurred in the 
case of experimental modulation of stress by raising 
the ambient temperature [16, 23]. Later, the sympatho-
adrenal link (mechanisms of urgent adaptation) begins 
to take part in this process, the active substances of 
which have an inhibitory effect on testosterone secre-
tion [17, 23]. Activation of the adrenocortical link causes 
the blocking of receptors on Leydig cells that synthe-
size testosterone and are exposed to GCS [18, 23]. At 
the same time, ACTH, which has a stimulating effect 
on neurons that secrete gonadotropins, enhances the 
production of gonadotropins [19, 23]. Given this, there 
is a paradoxical effect: when level of LH in the blood 
is increasing, there is a further significant decrease in 
testosterone levels [20,23]. Similar reactions in HPGS 
are inherent in the person. It is known that long-term or 
short-term exercises lead to an increase in cortisol le-
vels with unchanged LH with a simultaneous decrease 
in testosterone levels in men [21, 23]. During the simu-
lation of stress with reduced physical activity (immobili-
zation), the decrease in testosterone secretion unfolds 
in another pathogenetic way. The general decrease in 
physical activity is also inherent in long-term quaran-
tine isolation. In this case, corticoliberin blocks luliberin 
cells, which, accordingly, causes inhibition of LH and 
testosterone synthesis. One of the possible mecha-
nisms of testosterone reduction, not related to the se-
cretion of gonadotropins, is considered to be a shift in 
metabolism towards catabolic processes over anabolic 
ones due to hypersecretion of cortisol [22, 23].
Acute and chronic stress are accompanied by a 
significant increased risk of developing diabetes. For 
example, men with prediabetes have lower levels of 
total testosterone and sex hormone-binding globulin 
in their blood [29]. It should be added that total 
testosterone and sex hormone-binding globulin are 
independent risk factors for metabolic syndrome [36].
Hypogonadism occurs more often in men with a 
combination of type 2 diabetes and coronary heart 
disease (40 %) than in men with only type 2 diabetes 
(32 %) compared with the control group of healthy in-
dividuals (14 %) [34].
The metabolic syndrome deserves special consider-
ation. Metabolic syndrome and male hypogonadism are 
mutually determined and interdependent [30]. Metabolic 
syndrome, first described by Reaven in 1988 as "syn-
drome X", or "insulin resistance syndrome", is a group 
of common disorders, such as: insulin resistance, im-
paired glucose tolerance, abdominal obesity, decreased 
levels of HDL-cholesterol, and hypertension [31, 32, 33]. 
The general cause of such violations remains unknown 
today. However, this condition is considered to be the re-
sult of a sedentary lifestyle, overeating, and as a conse-
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quence – obesity, which is common in the modern world. 
Metabolic syndrome is associated with endothelial dys-
function and atherosclerosis, leading to an increased 
risk of cardiovascular disease and type 2 diabetes [31, 
32]. In the presence of metabolic syndrome, the levels of 
total and free testosterone in men were much lower than 
normal compared to women [35].
Stress and COVID-19. In addition to the above 
hormones, which directly and indirectly affect male 
hypogonadism and the body's protective reactions in 
particular, consider other hormones that obviously af-
fect the body under stress and the study of which is es-
pecially relevant for existing immuno-inflammatory, im-
muno-cytokine, oxidative mechanisms of development 
pathological conditions caused by COVID-19 infection.
Prolactin – one of the oldest hormones of the pi-
tuitary gland, which main function is to stimulate lac-
tation, is present in fairly large quantities in the male 
body. Receptors for prolactin are present in the cells of 
most tissues, which suggests that its role in the body 
is extremely multifaceted: prolactin is involved in al-
most all regulatory processes, having a synergistic or 
antagonistic effect on biologically active substances 
[23, 24]. The known anti-stress role of prolactin is de-
termined by the fact that it prevents the development 
of stress-induced catabolic reactions mediated by hy-
persecretion of GCS. Due to the extreme influence of 
various factors that contribute to the development of 
stress, there is a change in the content of prolactin in 
the blood (its dynamics largely depends on the dura-
tion and intensity of this effect) [23, 25]. Modeling of 
stress is accompanied by a significant increase in the 
concentration of prolactin, which offsets the catabolic 
effect of GCS. However, in the case of prolonged ex-
posure to stressors GCS is intensively produced due 
to the activation of the hypothalamic-pituitary-adrenal 
system, inhibits the secretion of prolactin until its com-
plete blockade [23, 26]. In this way, one of the most 
important compensatory links is deactivated with ap-
propriate preconditions for the development of stress.
Under the influence of stress, vasopressin acts 
inconsistently in the body. Thus, due to V1-receptors, 
which are located in vascular myocytes, liver and 
brain, under such powerful factors as stress, shock 
and a significant increase in blood pressure (which 
is also characteristic of stress), vasopressin plays a 
significant role, despite low affinity for such receptors. 
On the other hand, under the influence of adrenaline 
there is a decrease in vasopressin production. 
However, the effect of vasopressin on the kidneys 
and urination due to V2 receptors, which are located 
on the cell membranes of the distal tubules and 
collecting tubules of the kidneys, remains significant 
due to the possibility of increased blood pressure due 
to antidiuretic and vasospastic effects [27]. In addition 
to vasoconstrictive effects on the esophageal veins 
and glomerular capillaries, vasopressin also actively 
narrows the vessels of the coronary arteries, which may 
contribute to or exacerbate myocardial ischemia and 
hypoxia by supplementing the adrenomimetic action of 
catecholamine stress and systemic hypertension. 
During stress, due to the indirect stimulating effect 
of corticotropin-releasing hormone and ACTH, there 
is an increase in the production of glucocorticoids. 
The effects of cortisol during stress are so significant 
that it is even called the "enemy of health number 1" 
[28]. Chronic stress or constant anxiety does not pro-
vide a physical way out for cortisol and leads to the 
end of the "fight or flight" mechanism. This leads to 
unpleasant consequences. Ironically, human biology, 
which was supposed to ensure the survival of humans 
as hunters and gatherers, destroys the body and nous 
in a digital age with a sedentary lifestyle [28]. This im-
pact is even more pronounced in the context of social 
isolation during the COVID-19 pandemic. The cumu-
lative effect of an isolated and tense society causes 
an increase in cortisol levels in all directions for peo-
ple of all ages. This is creating a crisis in the health 
care system around the world.
Specify that cortisol contributes to anxiety, depres-
sion, headaches; weakening of the immune system; 
diseases of the cardiovascular system, hypertension, 
hyperglycemia and the development of diabetes mel-
litus; digestive problems.
There are ambiguous questions about the use 
and action of catecholamines in COVID-19 lesions. 
The use of adrenaline during resuscitation is the main 
means of eliminating cardiac arrest, but the safety 
and efficacy of this agent remain controversial. Va-
sopressin has been proposed as an alternative to 
adrenaline to eliminate cardiac arrest on the grounds 
that its levels were markedly higher in healthy patients 
than in those who had already died. Compared with 
adrenaline, vasopressin has a number of advantages, 
in particular, increases peripheral arterial resistance 
without direct stimulation of the myocardium; more 
resistant to acidosis and has a longer half-life; does 
not ignite – most importantly – a cytokine storm. Al-
though vasopressin was not shown to be superior to 
epinephrine in total cardiac arrest in any clinical trial, 
the use of vasopressin to relieve cardiac arrest in pa-
tients with COVID-19 should still be fully evaluated for 
cytokines. Given the need to balance the risks and 
benefits of treatment in clinical decisions, it seems 
timely to rethink the effects of epinephrine on patients 
with COVID-19 with a cytokine storm. The use of 
other agents (eg, vasopressin) should be compared 
with epinephrine, and their potential as an alternative 
strategy should be fully evaluated [37, 38, 39, 40].
Interesting was the fact that epinephrine enhances 
the cytokine storm during immunotherapy [41].
A significant change in the general hormonal 
background due to stress and immuno-cytokine, 
oxidative links of pathogenesis in the presence of 
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COVID-19 forces to pay special attention to the da mage 
not only to the lung tissue but also to the myocardium.
To date, the medical community has accumulated 
little data on the specifics of myocardial damage in the 
presence of COVID-19 [42]. However, scientists are 
unanimous in their view of the direct damaging effects 
of the SARS virus on the myocardium in general [43]. 
Acute heart disease, characterized by a significant in-
crease in cardiac troponin levels, is the most common 
(approximately 8–12% of all patients) among cardiac 
abnormalities caused by COVID-19. Direct damage 
to the myocardium due to viral damage to cardiomyo-
cytes and the effect of systemic inflammation should 
be considered, perhaps, the most common mecha-
nisms responsible for heart damage. Information on 
other manifestations of cardiovascular diseases due 
to COVID-19 remains very limited today. Neverthe-
less, it is known that the presence of cardiovascular 
disease in patients before COVID-19 and/or the de-
velopment of acute heart damage in them is associ-
ated with a much worse prognosis for them [44].
Hypogonadism and COVID-19. According to 
scientists, low testosterone levels are the reason 
for a worse prognosis for COVID-19 in men (much 
worse than for estrogen) [45]. A detailed study found 
that hypogonadism, which leads to testosterone defi-
ciency, can exacerbate a cytokine storm [46].
The researchers tracked some new pathophysi-
ological mechanisms of COVID-19's effects on the 
male reproductive system. Thus, SAR-CoV2 can act 
through several mechanisms of male reproductive 
dysfunction. The point is that the virus activates oxi-
dative stress (OS), which is a common pathological 
mechanism of disruption of certain physiological func-
tions due to oxidative tissue damage. OS-mediated 
mechanisms of male infertility are widely document-
ed, as OS affects sperm quality and disrupts sperm 
function and morphology [47]. Intracellular oxidative 
damage to sperm occurs due to lipid peroxidation of 
the sperm membrane, damage to sperm DNA, and 
induction of apoptotic pathways in sperm [47,48, 49]. 
During SARS-CoV infections, overproduction of re-
active oxygen species can trigger, for the most part, 
nuclear factor-enhancing kappa light chain pathways 
of activated B-cell (NF-κB) -toll-like receptors (mainly 
TLR-4) [50]. This further stimulates the release of cyo-
tokines, causing increased inflammatory responses 
[50]. As mentioned above, the virus can potentially 
cause orchitis, and later - the induction of OS. Even 
more, SARS-CoV-2 infection activates psychological 
stress, which is the main cause of systemic OS [51].
CONCLUSIONS
Comparison and analysis of the above makes it 
possible to trace an intricate and complex vicious circle 
(Figure 2), within one block of which, in turn, there are 
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their own inner vicious circles. Scientists around the 
world are working to be able to influence the weaker 
parts of the vicious circles at different levels. Given 
the above, one of the key points is to find a compro-
mise, the best option between the need for social iso-
lation through a pandemic and closer communication 
between people for mutual support (removal of stress 
from isolation).
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